InvestorsHub Logo
Followers 17
Posts 586
Boards Moderated 0
Alias Born 11/28/2013

Re: None

Friday, 10/24/2014 1:56:05 PM

Friday, October 24, 2014 1:56:05 PM

Post# of 6747
"Tekmira Pharmaceuticals Corporation Improved TKM-Ebola To Prove More Effective"



Clarus Securities analyst David Novak said in a research note that the improved TKM-Ebola has a greater probability of “demonstrating highest efficacy” against the current Ebola strain that is responsible for the epidemic. The Ebola virus mutates frequently as it reproduces. So, treatments that have been developed against an older strain would be less effective against the current strain of the virus.


http://www.valuewalk.com/2014/10/tekmira-tkmr-improve-tkm-ebola/



GLTA

IMO
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ABUS News